China’s first mRNA Covid-19 vaccine approved for clinical trials

On June 28, Walvax Biotechnology announced that the company, as a co-notifying party, had recently received the “Drug Clinical Trial Approval” for the mRNA Covid-19 vaccine approved by the State Drug Administration.

On June 28, Walvax Biotechnology announced that the company, as a co-notifying party, had recently received the “Drug Clinical Trial Approval” for the mRNA Covid-19 vaccine approved by the State Drug Administration.

The conclusion of the approval is that it is an emergency approval for the product for clinical trials, and the indication is to prevent diseases caused by SARS-CoV-2 infection (COVID-19).

The vaccine is China’s first mRNA coronavirus vaccine approved for clinical trials.

At present, only Covid-19 mRNA vaccines from a few countries such as the United States and Germany have entered clinical trials.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/29/china-s-first-mrna-covid-19-vaccine-approved-for-clinical-trials/.

Leave a Reply

Please Login to Comment